Johnson & Johnson (NYSE:JNJ) Stake Lessened by Navellier & Associates Inc.
Navellier & Associates Inc. lessened its stake in Johnson & Johnson (NYSE:JNJ – Free Report) by 4.9% during the third quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 17,177 shares of the company’s stock after selling 881 shares during the quarter. Navellier & Associates Inc.’s […]
More Stories
Hillstream BioPharma Terminates Agreement with Intract Pharma Ltd, Appoints New Board MemberWASHINGTON, D.C. — On November 20, 2024, Tharimmune, Inc., with its principal executive offices located in Bridgewater, New Jersey, filed a Form 8-K with the
This article was generated by an automated content engine and was reviewed by a human editor prior to publication. For...
CBRE Group, Inc. Announces Increase in Stock Repurchase Authorization
CBRE Group, Inc. (NYSE: CBRE) recently disclosed in a filing with the Securities and Exchange Commission that its Board of...
Fura Gems (CVE:FURA) Stock Price Down 3.3% – Time to Sell?
Fura Gems Inc. (CVE:FURA – Get Free Report) shares dropped 3.3% during trading on Tuesday . The stock traded as...
Yangarra Resources (OTCMKTS:YGRAF) Stock Price Up 1.5% – Time to Buy?
Yangarra Resources Ltd. (OTCMKTS:YGRAF – Get Free Report)’s stock price traded up 1.5% during trading on Tuesday . The company...
Pharos Energy (LON:PHAR) Trading 1.1% Higher – Should You Buy?
Pharos Energy plc (LON:PHAR – Get Free Report) shares were up 1.1% on Tuesday . The stock traded as high...
Cannabist (OTCMKTS:CCHWF) Shares Down 6.4% – Should You Sell?
The Cannabist Company Holdings Inc. (OTCMKTS:CCHWF – Get Free Report)’s share price was down 6.4% during mid-day trading on Tuesday...